Literature DB >> 10865857

Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells.

N Kume1, H Moriwaki, H Kataoka, M Minami, T Murase, T Sawamura, T Masaki, T Kita.   

Abstract

Macrophages appear to take up oxidized low density lipoprotein (Ox-LDL) by multiple receptor-mediated pathways. This study, therefore, has been performed to determine if LOX-1, a novel receptor for Ox-LDL, which was identified in vascular endothelial cells, is also expressed in macrophages. Expression of LOX-1 can be induced after macrophage-like differentiation in human peripheral blood monocytes as well as THP-1 cells. Furthermore, expression of LOX-1 in macrophages is also upregulated by an inflammatory cytokine TNF-alpha, which was shown to be present in atherosclerotic arterial wall. Expression of this novel receptor LOX-1 may play an important role in Ox-LDL uptake and subsequent foam cell formation in macrophages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865857     DOI: 10.1111/j.1749-6632.2000.tb06332.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

Review 1.  New scavenger receptors and their functions in atherogenesis.

Authors:  Noriaki Kume; Toru Kita
Journal:  Curr Atheroscler Rep       Date:  2002-07       Impact factor: 5.113

2.  Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE-/- (Apolipoprotein E Deficient) Mice.

Authors:  Min Zhang; Xianqiu Zeng; Qiuhua Yang; Jiean Xu; Zhiping Liu; Yaqi Zhou; Yapeng Cao; Xiaoyu Zhang; Xiaofei An; Yiming Xu; Lei Huang; Zhen Han; Tao Wang; Chaodong Wu; David J Fulton; Neal L Weintraub; Mei Hong; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

Review 3.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 4.  Mechanisms of foam cell formation in atherosclerosis.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  J Mol Med (Berl)       Date:  2017-08-07       Impact factor: 4.599

Review 5.  Regulation of foam cells by adenosine.

Authors:  Allison B Reiss; Bruce N Cronstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

6.  Blockade of LOX-1 prevents endotoxin-induced acute lung inflammation and injury in mice.

Authors:  Ping Zhang; Ming-Cheh Liu; Lili Cheng; Mei Liang; Hong-long Ji; Jian Fu
Journal:  J Innate Immun       Date:  2008-10-01       Impact factor: 7.349

7.  Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques.

Authors:  Lander Egaña-Gorroño; Prameladevi Chinnasamy; Isabel Casimiro; Vanessa M Almonte; Dippal Parikh; Gustavo H Oliveira-Paula; Smitha Jayakumar; Calvin Law; Dario F Riascos-Bernal; Nicholas E S Sibinga
Journal:  Atherosclerosis       Date:  2019-07-26       Impact factor: 5.162

8.  LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.

Authors:  David F Schaeffer; Maziar Riazy; Kuljit S Parhar; Johnny H Chen; Vincent Duronio; Tatsuya Sawamura; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-04-09       Impact factor: 5.922

9.  Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro.

Authors:  Jun Yu; Yan Li; Mincai Li; Zhiling Qu; Qiurong Ruan
Journal:  Int J Exp Pathol       Date:  2010-02       Impact factor: 1.925

10.  Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury.

Authors:  Li Jin; Nicole E Hastings; Brett R Blackman; Avril V Somlyo
Journal:  J Muscle Res Cell Motil       Date:  2009-02-10       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.